AmSurg Hits Estimates in Solid Quarter
AmSurg (NAS: AMSG) reported earnings on Oct. 23. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended Sep. 30 (Q3), AmSurg met expectations on revenues and met expectations on earnings per share.
Compared to the prior-year quarter, revenue grew significantly and GAAP earnings per share expanded significantly.
Gross margins contracted, operating margins dropped, net margins grew.
AmSurg reported revenue of $226.4 million. The eight analysts polled by S&P Capital IQ wanted to see revenue of $226.0 million on the same basis. GAAP reported sales were 16% higher than the prior-year quarter's $195.9 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $0.49. The nine earnings estimates compiled by S&P Capital IQ averaged $0.49 per share. GAAP EPS of $0.49 for Q3 were 17% higher than the prior-year quarter's $0.42 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 53.9%, 210 basis points worse than the prior-year quarter. Operating margin was 29.7%, 100 basis points worse than the prior-year quarter. Net margin was 6.8%, 10 basis points better than the prior-year quarter.
Next quarter's average estimate for revenue is $237.6 million. On the bottom line, the average EPS estimate is $0.51.
Next year's average estimate for revenue is $928.3 million. The average EPS estimate is $2.01.
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 137 members out of 147 rating the stock outperform, and 10 members rating it underperform. Among 45 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 42 give AmSurg a green thumbs-up, and three give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on AmSurg is hold, with an average price target of $28.86.
- Add AmSurg to My Watchlist.
The article AmSurg Hits Estimates in Solid Quarter originally appeared on Fool.com.Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor ofMotley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no positions in the stocks mentioned above. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.